RAC 1.18% $1.67 race oncology ltd

Industry news, page-1837

  1. 1,882 Posts.
    lightbulb Created with Sketch. 465
    Excellent post; this is what needs to be pressed home to all who are over exposed on RAC, yes I’m a buyer but a cautious buyer.
    If I may ask a question it’s this:-
    If the trial wasn’t to investigate the cardio protective effects of Bisantrene in combination with Dox, would RAC be able to get a combination trial underway to investigate the cancer fighting effects of Bisantrene?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.